Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 22, 2017

View Archived Issues

CCAT1 and CCAT2 long noncoding RNAs as novel prognostic biomarkers in colorectal cancer

Novel role of APLNR gene in regulating the response to cancer immunotherapy

TFAM overexpression rescues sperm defects in infertile mtDNA mutator mice

Effective in vivo Mnk1/2 inhibitors identified for blast crisis chronic myelogenous leukemia

Amgen's cyclopropyloxazines, a new series of BACE1 inhibitors for Alzheimer's disease

FDA approves Duzallo to treat hyperuricemia associated with gout

Samsung Bioepis and Takeda begin strategic biologic codevelopment collaboration

Alkermes begins rolling NDA submission for ALKS-5461 as adjuvant treatment of MDD

Chiesi discovers new phosphatidylinositol 3-kinase inhibitors

Novel 5-HT-2 receptor antagonists patented by Shenzhen Targetrx Biotechnology

Jiangsu Chia Tai Tianqing, Centaurus BioPharma and Lianyungang Ruzhong present new BET inhibitors

FDA grants orphan drug designation to SY-1425 for AML

European Commission approves new indication for Soliris in refractory generalized myasthenia gravis

Ilkos Therapeutic initiates phase II study of S-42909 for leg ulcer healing

Trovagene's PCM-075 shows synergy with HDAC inhibitor in NHL cell lines

BioLineRx files regulatory submissions to begin phase III study of BL-8040 in stem cell mobilization

FDA advises on Cardiome's planned NDA resubmission for Brinavess

Patient enrollment under way in first-in-human trial of M-8891

Mavyret now available in U.S. for chronic HCV

Dr. Reddy's reports out-licensing of DFD-06 to Encore Dermatology

Sorrento announces contribution to formation of Celularity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...